These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

149 related items for PubMed ID: 14709834

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Persistent increase in bone turnover in Graves' patients with subclinical hyperthyroidism.
    Kumeda Y, Inaba M, Tahara H, Kurioka Y, Ishikawa T, Morii H, Nishizawa Y.
    J Clin Endocrinol Metab; 2000 Nov; 85(11):4157-61. PubMed ID: 11095447
    [Abstract] [Full Text] [Related]

  • 3. Bone remodelling markers and serum cytokines in patients with hyperthyroidism.
    Akalin A, Colak O, Alatas O, Efe B.
    Clin Endocrinol (Oxf); 2002 Jul; 57(1):125-9. PubMed ID: 12100080
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Sclerostin and bone metabolism markers in hyperthyroidism before treatment and interrelations between them.
    Sarıtekin İ, Açıkgöz Ş, Bayraktaroğlu T, Kuzu F, Can M, Güven B, Mungan G, Büyükuysal Ç, Sarıkaya S.
    Acta Biochim Pol; 2017 Jul; 64(4):597-602. PubMed ID: 29059259
    [Abstract] [Full Text] [Related]

  • 9. Changes in parameters of bone and mineral metabolism during therapy for hyperthyroidism.
    Pantazi H, Papapetrou PD.
    J Clin Endocrinol Metab; 2000 Mar; 85(3):1099-106. PubMed ID: 10720046
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Serum concentrations of osteocalcin in patients with hyperthyroidism, hypothyroidism and subacute thyroiditis.
    Kojima N, Sakata S, Nakamura S, Nagai K, Takuno H, Ogawa T, Matsui I, Sarui H, Miura K.
    J Endocrinol Invest; 1992 Mar; 15(7):491-6. PubMed ID: 1447487
    [Abstract] [Full Text] [Related]

  • 14. Serum interleukin-6 and bone metabolism in patients with thyroid function disorders.
    Lakatos P, Foldes J, Horvath C, Kiss L, Tatrai A, Takacs I, Tarjan G, Stern PH.
    J Clin Endocrinol Metab; 1997 Jan; 82(1):78-81. PubMed ID: 8989237
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Restoration of euthyroidism accelerates bone turnover in patients with subclinical hypothyroidism: a randomized controlled trial.
    Meier C, Beat M, Guglielmetti M, Christ-Crain M, Staub JJ, Kraenzlin M.
    Osteoporos Int; 2004 Mar; 15(3):209-16. PubMed ID: 14727010
    [Abstract] [Full Text] [Related]

  • 19. [Serum osteocalcin in hyperthyroidism].
    Roiter I, Legovini P, Da Rin G, Galliazzo S, Di Virgilio R, Foscolo G, Breda F, Conte N.
    Ann Ital Med Int; 1990 Mar; 5(2):95-9. PubMed ID: 2248865
    [Abstract] [Full Text] [Related]

  • 20. Plasma levels of NT-pro-brain natriuretic peptide in patients with overt and subclinical hyperthyroidism and hypothyroidism.
    Pakuła D, Marek B, Kajdaniuk D, Krysiak R, Kos-Kudła B, Pakuła P, Gatnar A, Borgiel-Marek H, Nowak M, Siemińska L, Głogowska-Szeląg J, Ostrowska Z.
    Endokrynol Pol; 2011 Mar; 62(6):523-8. PubMed ID: 22144219
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.